AN INVESTIGATIONAL IMMUNO-THERAPY STUDY OF EXPERIMENTAL MEDICATION BMS-986178 BY ITSELF OR IN COMBINATION WITH NIVOLUMAB AND/OR IPILIMUMAB IN PATIENTS WITH SOLID CANCERS THAT ARE ADVANCED OR HAVE SPREAD: